Literature DB >> 7169982

Parathyroid function and lipid metabolism in the rat.

B Lacour, C Basile, T Drüeke, J L Funck-Brentano.   

Abstract

The present investigation in experimental animals was designed to obtain further insight into the possible role of parathyroid hormone (PTH) in lipid metabolism. An endogenous hyperparathyroid state was induced in rats by a calcium-poor diet. This type of hyperparathyroidism was associated with a significant increase in serum cholesterol and triglyceride concentrations, a significant decrease in the serum clearance rate of intravenously infused Intralipid and a significant increase in hepatic tissue triglyceride content as compared to the values obtained in control animals. An exogenous type of hyperparathyroidism (parathyroid extract injections) was also accompanied by a slight increase in serum cholesterol and triglyceride concentrations as well as a decrease in plasma postheparin lipolytic activity (PHLA), but the changes did not reach the level of statistical significance. In the aparathyroid state, a significant decrease in serum cholesterol and triglyceride concentrations and a significant increase in plasma PHLA were observed as compared to control rats. In additional studies, it could be demonstrated that the endogenous hyperparathyroid state was not associated with increased intestinal absorption of [3H]triolein as compared to control animals. Furthermore, the hepatic triglyceride secretion rate in these hyperparathyroid rats was significantly lower than in normal rats. In conclusion, hyperparathyroidism induces an increase in serum cholesterol and triglyceride concentrations, the latter being due to decreased peripheral removal. The aparathyroid state induces opposite changes. Thus, normal parathyroid function is required for normal lipid metabolism in the rat.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7169982

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  7 in total

1.  Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study.

Authors:  E Wehr; T R Pieber; B Obermayer-Pietsch
Journal:  J Endocrinol Invest       Date:  2011-05-24       Impact factor: 4.256

2.  Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women.

Authors:  Sara A Chacko; Yiqing Song; JoAnn E Manson; Linda Van Horn; Charles Eaton; Lisa W Martin; Anne McTiernan; J David Curb; Judith Wylie-Rosett; Lawrence S Phillips; Raymond A Plodkowski; Simin Liu
Journal:  Am J Clin Nutr       Date:  2011-05-25       Impact factor: 7.045

3.  Vitamin D deficiency is an independent predictor of elevated triglycerides in Spanish school children.

Authors:  Elena Rodríguez-Rodríguez; Rosa M Ortega; Liliana G González-Rodríguez; Ana M López-Sobaler
Journal:  Eur J Nutr       Date:  2010-11-20       Impact factor: 5.614

4.  Effects of vitamin D supplementation on cardiometabolic outcomes in children and adolescents: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Hanne Hauger; Rikke Pilmann Laursen; Christian Ritz; Christian Mølgaard; Mads Vendelbo Lind; Camilla Trab Damsgaard
Journal:  Eur J Nutr       Date:  2020-02-14       Impact factor: 5.614

5.  Deficiency of 25-hydroxyvitamin d and dyslipidemia in Indian subjects.

Authors:  Jaydip Ray Chaudhuri; K Rukmini Mridula; Alluri Anamika; Demudu Babu Boddu; Pradeep Kumar Misra; A Lingaiah; Banda Balaraju; Vcs Srinivasarao Bandaru
Journal:  J Lipids       Date:  2013-12-18

6.  A new perspective on cholesterol in pediatric health: association of vitamin D metabolism, respiratory diseases, and mental health problems.

Authors:  Jeana Hong
Journal:  Clin Exp Pediatr       Date:  2021-12-09

7.  The Effect of Vitamin D Supplementation on Blood Lipids in Minorities with Type 2 Diabetes.

Authors:  Joel C Exebio; Sahar Ajabshir; Adriana Campa; Tan Li; Gustavo G Zarini; Fatma G Huffman
Journal:  Int J Diabetes Clin Res       Date:  2018-09-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.